At MUSC Health’s Structural Heart & Valve Center, you have access to the most innovative heart valve repair and replacement options available. You can trust our:
MUSC Health’s Structural Heart & Valve Center offers more treatment options for heart valve disease than any other center in South Carolina. Our doctors have decades of experience resolving faulty heart valve problems.
In addition to traditional open-heart surgery to repair or replace faulty heart valves, we offer:
MUSC Health is South Carolina's most experienced center for transcatheter structural heart procedures including transcatheter edge-to-edge repair (TEER) for mitral and tricuspid valve disease, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), and transcatheter tricuspid valve replacement (TTVR). We were the first in South Carolina to offer many of these procedures, including the state's first implant of Evoque, the only FDA-approved transcatheter tricuspid valve replacement device. We use multiple FDA-approved devices across all of these approaches, so your care is tailored to your anatomy and condition, not limited by what a single device can do.
MUSC Health is South Carolina's most experienced center for transcatheter edge-to-edge repair (TEER), a minimally invasive approach to treating leaky heart valves without open-heart surgery.
TEER is used to treat both mitral regurgitation and tricuspid regurgitation — conditions where faulty valve leaflets allow blood to flow backward through the heart, forcing it to work harder. Left untreated, these conditions increase the risk of heart arrhythmia and heart failure over time.
Our heart valve specialists have been at the forefront of TEER since its earliest clinical use. We use multiple FDA-approved devices to perform both mitral and tricuspid repairs, allowing us to tailor the approach to your specific anatomy and condition — not just what a single device can offer.
During a TEER procedure, our specialists insert a catheter through a blood vessel in your groin and guide a small clip-like device directly onto the leaking valve leaflets, drawing them together to reduce or eliminate the leak. The result is improved valve function with a faster recovery than traditional open-heart surgery.
Beyond repair, our team offers transcatheter valve replacement options for patients whose anatomy or condition requires a more complete solution, no open-heart surgery required.
For patients with mitral valve disease who are not good candidates for repair, MUSC Health offers transcatheter mitral valve replacement (TMVR) — a question we hear often from referring physicians across the region. Our team has the experience and technology to evaluate and treat these complex cases, offering patients options that may not be available closer to home.
MUSC Health's Charleston division was the first in South Carolina to implant the Evoque transcatheter tricuspid valve replacement system, the only FDA-approved device of its kind for tricuspid valve disease. This is a significant capability distinction: tricuspid valve disease has historically been undertreated, and transcatheter replacement is an emerging option that few centers in the country are equipped to offer. Our team is among them.